Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Bras Nefrol ; 42(2 suppl 1): 44-46, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-2293806

ABSTRACT

INTRODUCTION: Palliative care is an approach aimed at relieving suffering, controlling symptoms and seeking to improve quality of life. It must be offered in conjunction with standard treatment for any disease that threatens the continuation of life, such as a Covid-19 infection. DISCUSSION: The bioethical principles and strategies used by palliative medicine can assist nephrologists in the care of patients with renal dysfunction, who face the difficulties of isolation at the beginning and follow-up of dialysis in outpatient treatment, and those who are at risk for a more serious disease progress. Some of them: - a Shared decision making, which enables the patient and family to participate as facilitators in the systematization of the team's reasoning, in addition to respecting the principle of autonomy; - Symptom Management: which should be a priority to ensure relief of suffering even in times of social isolation; - Communication skills: making it possible to alleviate suffering in announcing bad news or complex decisions through communication techniques;; - Bereavement assistance: which in acute situations such as the pandemic, causing unexpected losses, the importance of sympathy from healthcare professionals becomes even greater. CONCLUSION: The principles of palliative care are essential to face the challenges of a planet-wide crisis, which raises human suffering in all dimensions, and which requires the construction of strategies that can keep patients assisted, comfortable and with measures proportional to their clinical condition and preferences.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Palliative Care/methods , Pneumonia, Viral/epidemiology , Renal Replacement Therapy/standards , Bereavement , COVID-19 , Communication , Decision Making, Shared , Humans , Nephrology/standards , Pandemics , Renal Replacement Therapy/methods , SARS-CoV-2 , Symptom Assessment/methods
2.
J Bras Nefrol ; 42(2 suppl 1): 12-14, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-2291145

ABSTRACT

Patients with Chronic Kidney Disease are among those individuals at increased risk for developing more serious forms of Covid-19. This increased risk starts in the pre-dialysis phase of the disease. Providing useful information for these patients, in language that facilitates the understanding of the disease, can help nephrologists and other healthcare professionals to establish a more effective communication with these patients and help minimize contagion and the risks of serious illness in this population.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Patient Education as Topic/standards , Pneumonia, Viral/prevention & control , Renal Insufficiency, Chronic/complications , Activities of Daily Living , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Elective Surgical Procedures , Hand Hygiene/methods , Hand Hygiene/standards , Health Facilities , Health Personnel , Humans , Nephrology/standards , Personal Space , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Renal Dialysis , Risk Factors , SARS-CoV-2 , Symptom Assessment
3.
J Bras Nefrol ; 42(2 suppl 1): 4-8, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-845305

ABSTRACT

The Covid-19 pandemic brought several challenges to the healthcare system: diagnosis, treatment and measures to prevent the spread of the disease. With the greater availability and variety of diagnostic tests, it is essential to properly interpret them. This paper intends to help dialysis units concerning the use of clinical criteria and diagnostic tests for decision making regarding the discontinuation of isolation of patients with suspected or confirmed Covid-19, as well as the return to work activities for employees with suspected or confirmed Covid-19.


Subject(s)
Betacoronavirus , Clinical Laboratory Techniques/standards , Coronavirus Infections/diagnosis , Nephrology/standards , Pneumonia, Viral/diagnosis , Renal Dialysis , Return to Work , Algorithms , Brazil , COVID-19 , COVID-19 Testing , Checklist , Clinical Decision-Making , Clinical Laboratory Techniques/methods , Coronavirus Infections/epidemiology , Humans , Occupational Diseases/diagnosis , Pandemics , Patient Isolation , Pneumonia, Viral/epidemiology , Real-Time Polymerase Chain Reaction/methods , Real-Time Polymerase Chain Reaction/standards , SARS-CoV-2 , Societies, Medical/standards , Urology Department, Hospital/standards
4.
Am J Kidney Dis ; 77(1): 142-148, 2021 01.
Article in English | MEDLINE | ID: covidwho-799495

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic, technological advancements, regulatory waivers, and user acceptance have converged to boost telehealth activities. Due to the state of emergency, regulatory waivers in the United States have made it possible for providers to deliver and bill for services across state lines for new and established patients through Health Insurance Portability and Accountability Act (HIPAA)- and non-HIPAA-compliant platforms with home as the originating site and without geographic restrictions. Platforms have been developed or purchased to perform videoconferencing, and interdisciplinary dialysis teams have adapted to perform virtual visits. Telehealth experiences and challenges encountered by dialysis providers, clinicians, nurses, and patients have exposed health care disparities in areas such as access to care, bandwidth connectivity, availability of devices to perform telehealth, and socioeconomic and language barriers. Future directions in telehealth use, quality measures, and research in telehealth use need to be explored. Telehealth during the public health emergency has changed the practice of health care, with the post-COVID-19 world unlikely to resemble the prior era. The future impact of telehealth in patient care in the United States remains to be seen, especially in the context of the Advancing American Kidney Health Initiative.


Subject(s)
Advisory Committees/standards , Hemodialysis, Home/standards , Kidney Failure, Chronic/epidemiology , Nephrology/standards , Societies, Medical/standards , Telemedicine/standards , Advisory Committees/trends , Hemodialysis, Home/trends , Humans , Kidney Failure, Chronic/therapy , Nephrology/trends , Societies, Medical/trends , Telemedicine/trends , United States/epidemiology
5.
J Bras Nefrol ; 42(2 suppl 1): 41-43, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-740465

ABSTRACT

Vascular accesses for hemodialysis are considered the patient's lifeline and their maintenance is essential for treatment continuity. Following the example of institutions in other countries affected by the Covid-19 pandemic, the Brazilian Society of Nephrology developed these guidelines for healthcare services, elaborating on the importance of carrying out procedures for the preparation and preservation of vascular accesses. Creating definitive accesses for hemodialysis, grafts and arteriovenous fistulas are non-elective procedures, as well as the transition from the use of non-tunneled catheters to tunneled catheters, which cause less morbidity. In the case of patients with suspected or confirmed coronavirus infection, one may postpone the procedures for the quarantine period, to avoid spreading the disease.


Subject(s)
Arteriovenous Shunt, Surgical/methods , Betacoronavirus , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Renal Dialysis/methods , Vascular Access Devices , Advisory Committees , Arteriovenous Shunt, Surgical/standards , Brazil , COVID-19 , Elective Surgical Procedures/methods , Elective Surgical Procedures/standards , Emergencies , Humans , Nephrology/standards , Pandemics , SARS-CoV-2 , Societies, Medical
6.
J Bras Nefrol ; 42(2 suppl 1): 32-35, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-740463

ABSTRACT

INTRODUCTION: The impact of the new coronavirus (SARS-COV-2) and its worldwide clinical manifestations (COVID-19) imposed specific regional recommendations for populations in need of specialized care, such as children and adolescents with kidney diseases, particularly in renal replacement therapies (RRT). We present the recommendations of the Brazilian Society of Nephrology regarding the treatment of pediatric patients with kidney diseases during the COVID-19 pandemic. METHODS: Articles and documents from medical societies and government agencies on specific recommendations for children on RRT in relation to COVID-19 as well as those focused on epidemiological aspects of this condition in Brazil Were evaluated and analyzed. RESULTS: We present recommendations on outpatient care, transportation to dialysis centers, peritoneal dialysis, hemodialysis, and kidney transplantation in children and adolescents during the COVID-19 pandemic in Brazil. DISCUSSION: Despite initial observations of higher mortality rates in specific age groups (the elderly) and with comorbidities (obese, diabetics, and those with cardiovascular diseases), patients with chronic kidney disease (CKD) on RRT are particularly prone to develop COVID-19. Specific measures must be taken to reduce the risk of contracting SARS-CoV-2 and developing COVID-19, especially during transport to dialysis facilities, as well as on arrival and in contact with other patients.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Kidney Diseases/therapy , Pneumonia, Viral/epidemiology , Renal Replacement Therapy/standards , Adolescent , Ambulatory Care , Brazil/epidemiology , COVID-19 , Child , Coronavirus Infections/diagnosis , Coronavirus Infections/prevention & control , Coronavirus Infections/transmission , Humans , Hygiene/standards , Kidney Transplantation , Masks , Nephrology/standards , Occupational Diseases/prevention & control , Pandemics/prevention & control , Patient Isolation , Pediatrics , Pneumonia, Viral/diagnosis , Pneumonia, Viral/prevention & control , Pneumonia, Viral/transmission , Renal Replacement Therapy/methods , SARS-CoV-2 , Societies, Medical , Symptom Assessment , Transportation of Patients
7.
J Bras Nefrol ; 42(2 suppl 1): 22-31, 2020 08 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-740462

ABSTRACT

We produced this document to bring pertinent information to the practice of nephrology, as regards to the renal involvement with COVID-19, the management of acute kidney injury cases, and practical guidance on the provision of dialysis support.As information on COVID-19 evolves at a pace never before seen in medical science, these recommendations, although based on recent scientific evidence, refer to the present moment. The guidelines may be updated when published data and other relevant information become available.


Subject(s)
Acute Kidney Injury/therapy , Betacoronavirus , Coronavirus Infections/epidemiology , Pneumonia, Viral/epidemiology , Renal Replacement Therapy/standards , Vascular Access Devices/standards , Acute Kidney Injury/epidemiology , Acute Kidney Injury/etiology , Brazil/epidemiology , COVID-19 , Clinical Decision-Making , Coronavirus Infections/drug therapy , Coronavirus Infections/prevention & control , Critical Care , Humans , Kidney/drug effects , Nephrology/standards , Occupational Diseases/prevention & control , Pandemics/prevention & control , Personal Protective Equipment , Pneumonia, Viral/drug therapy , Pneumonia, Viral/prevention & control , Recovery of Function , Renal Replacement Therapy/methods , Respiration, Artificial/adverse effects , SARS-CoV-2 , Societies, Medical
8.
J Bras Nefrol ; 42(2 suppl 1): 18-21, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-740461

ABSTRACT

Considering the new coronavirus epidemic (Covid-19), the Brazilian Society of Nephrology, represented by the Peritoneal Steering Committee, in agreement with the and the Dialysis Department, developed a series of recommendations for good clinical practices for peritoneal dialysis (PD) clinics, to be considered during the period of the Covid-19 epidemic. We aim to minimize the disease spread, protecting patients and staff, and ensuring the quality of the treatment provided and adequate follow-up for PD patients. The recommendations suggested at this moment must be adapted to each clinic's reality and the conditions of the structural and human resources, dependent on the adequate financial provision of the public health system for its full implementation.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Kidney Failure, Chronic/therapy , Pandemics/prevention & control , Peritoneal Dialysis/standards , Pneumonia, Viral/prevention & control , Brazil , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Disinfection/methods , Disinfection/standards , Humans , Kidney Failure, Chronic/complications , Masks , Nephrology/standards , Occupational Diseases/prevention & control , Patient Care Team , Patient Education as Topic , Patient Isolation/methods , Patient Isolation/standards , Peritoneal Dialysis/instrumentation , Peritoneal Dialysis/methods , Personal Protective Equipment , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , SARS-CoV-2 , Societies, Medical , Telemedicine/legislation & jurisprudence , Telemedicine/methods , Telemedicine/standards , Urology Department, Hospital/organization & administration , Urology Department, Hospital/standards
9.
J Bras Nefrol ; 42(2 suppl 1): 15-17, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-740460

ABSTRACT

Dialysis units are environments potentially prone to the spread of Covid-19. Patients cannot suspend treatment, and they often have comorbidities, which assigns them a higher risk and worse prognosis. The Brazilian Society of Nephrology prepared this document of good practices, whose technical recommendations deal with general measures that can be implemented to reduce the risk of transmission and prevent the spread of the disease in the unit.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Pandemics/prevention & control , Pneumonia, Viral/prevention & control , Renal Dialysis/standards , Urology Department, Hospital/standards , Brazil , COVID-19 , Coronavirus Infections/diagnosis , Coronavirus Infections/epidemiology , Coronavirus Infections/transmission , Disinfection/methods , Disinfection/standards , Humans , Masks , Nephrology/standards , Patient Isolation/methods , Patient Isolation/standards , Personal Protective Equipment , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Pneumonia, Viral/transmission , Renal Insufficiency, Chronic , SARS-CoV-2 , Societies, Medical/standards , Symptom Assessment
10.
J Bras Nefrol ; 42(2 suppl 1): 9-11, 2020 Aug 26.
Article in English, Portuguese | MEDLINE | ID: covidwho-740458

ABSTRACT

These recommendations were created after the publication of informative note 3/2020- CGGAP/DESF/SAPS/MS, of April 4, 2020, in which the Brazilian Ministry of Health recommended the use of a cloth mask by the population, in public places. Taking into account the necessary prioritization of the provision of Personal Protective Equipment (PPE) for patients with suspected or confirmed disease, as well as for healthcare professionals, the SBN is favorable concerning the wear of cloth masks by chronic kidney patients in dialysis, in public settings, except in the dialysis setting. The present recommendations have eleven items, related to this rationale, the procedures, indications, contraindications, as well as appropriate fabrics for the mask, and hygiene care to be adopted. These recommendations may change, at any time, in the light of new evidence.


Subject(s)
Betacoronavirus , Coronavirus Infections/prevention & control , Masks/standards , Pandemics/prevention & control , Personal Protective Equipment/standards , Pneumonia, Viral/prevention & control , Renal Dialysis , Textiles , Brazil , COVID-19 , Coronavirus Infections/epidemiology , Health Personnel , Humans , Nephrology/standards , Occupational Diseases/prevention & control , Pneumonia, Viral/epidemiology , Protective Clothing/standards , Renal Insufficiency, Chronic/therapy , SARS-CoV-2 , Societies, Medical , Urology Department, Hospital/standards
11.
Nephrol Dial Transplant ; 35(6): 920-925, 2020 06 01.
Article in English | MEDLINE | ID: covidwho-343463

ABSTRACT

The coronavirus disease 2019 (COVID-19) pandemic has created major challenges for all countries around the globe. Retrospective studies have identified hypertension, cardiovascular disease, diabetes and older age as risk factors for high morbidity and mortality from COVID-19. There is a general concern that patients with immune-mediated kidney diseases, namely those on immunosuppressive therapies and/or those with more advanced kidney failure, could particularly be at risk for adverse outcomes due to a compromised antiviral immunity. Uncertainties exist on how management routines should be reorganized to minimize the risk of severe acute respiratory syndrome coronavirus 2 infection and what measures are necessary for infected patients. The aim of the present review of the Immunonephrology Working Group of the European Renal Association-European Dialysis and Transplant Association is to provide recommendations for the management of patients with immune-mediated kidney diseases based on the available evidence, similar circumstances with other infectious organisms and expert opinions from across Europe. Such recommendations may help to minimize the risk of encountering COVID-19 or developing complications during COVID-19 in patients with immune-mediated kidney disease.


Subject(s)
Coronavirus Infections/immunology , Coronavirus Infections/therapy , Kidney Diseases/immunology , Kidney Diseases/therapy , Nephrology/standards , Pneumonia, Viral/immunology , Pneumonia, Viral/therapy , Antiviral Agents , Betacoronavirus , COVID-19 , Coronavirus Infections/complications , Europe , Humans , Immunosuppressive Agents/therapeutic use , Kidney Diseases/complications , Pandemics , Pneumonia, Viral/complications , Renal Dialysis , Retrospective Studies , Risk Assessment , Risk Factors , SARS-CoV-2 , Societies, Medical
SELECTION OF CITATIONS
SEARCH DETAIL